Latest News - Roche

Tuesday, January 16, 2018

Roche CEO Says Upcoming Patent Losses Putting Pressure on Profitability

Roche chief executive Severin Schwan acknowledged that some of the company's "highly profitable medicines [are] coming off patent," and while it has new medicines "to ramp up&hellip…

Read the full story

Friday, July 08, 2016

Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031

Eleven Biotherapeutics announced that the company’s investigational new drug application for EBI-031, a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all kn…

Read the full story

Monday, June 13, 2016

Eleven Biotherapeutics Announces Signing of Exclusive License Agreement with Roche

Eleven Biotherapeutics announced that it has entered into an exclusive license agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) relating to Eleven’s Interleukin-6 (IL-…

Read the full story

Wednesday, November 18, 2015

Genentech Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech/Novartis Ex-US Agreement for Fovista to Treat Wet AMD

Ophthotech announced that Genentech has elected to exercise its option to participate in the financial arrangements relating to Novartis’ rights under the Ophthotech/Novartis ex-US agreement for…

Read the full story